Summary
Aware reported fourth-quarter revenue of $4.37 million, up 7.7% from the prior-year quarter. Full-year revenue reached $18.24 million, up 14.0%. The top line grew, but profitability deteriorated sharply. The quarter's operating loss was $4.48 million, and the loss widened 121.9% from the prior-year quarter. For the full year, the operating loss was $8.54 million, a 285.2% widening. The net loss was $4.24 million in the quarter, 141.3% wider than a year earlier, and $7.31 million for the full year, 323.8% wider. Diluted EPS for the full year was -$0.35, and the loss per share widened 337.5%. Operating margin was -102.5% in the quarter, down 52.8 percentage points, and -46.8% for the full year, down 33.0 percentage points.
Cash generation improved even as losses widened. Operating cash flow was $3.06 million in the quarter, up 737.2% from the prior-year quarter. For the full year, operating cash flow was $1.82 million, up 136.2%. Capital expenditures were $0.00 million in the quarter, down 100.0%, and $0.02 million for the full year, down 97.8%. Deferred revenue was $5.54 million at year-end, up 48.3% from the prior-year quarter. Remaining performance obligations stood at $0.60 million.
The revenue mix shifted toward software licenses. Software license revenue rose 30% and climbed from 46% to 52% of total revenue. Software maintenance revenue rose 8% but slipped from 44% to 42% of total revenue. Services and other revenue fell 31% and declined from 9% to 6% of total revenue. Management pointed to AwareID as a future SaaS offering. SaaS revenue was de minimis in 2023 and 2022, but the company expects SaaS to become a significant product offering. Total engineering costs fell 1% and dropped from 66% to 57% of total revenue. Engineering headcount decreased from 46 in 2022 to 42 in 2023. Additional actions cut engineering headcount by approximately 10%.
Management offered limited forward guidance. Research and development expense is expected to decrease in absolute dollars and as a percentage of revenues in the next year, then increase in absolute dollars in subsequent years. General and administrative expense is expected to increase in absolute dollars but decrease as a percentage of total revenue. Selling and marketing spending will be strategic. The main risks center on the Omlis note receivable. Its carrying value was written down, and Omlis and MIRACL petitioned to enter the United Kingdom administration process in January 2024, adding uncertainty about recoverability. The FortressID earnout period closed with no targets met. Inflation has not materially affected results to date, but the company warns it could in the future. Aware believes its cash resources will fund operations for at least the next twelve months.
The company also faces lease obligations. It estimates payments under its corporate headquarters operating lease of approximately $0.7 million in each of 2024, 2025, 2026, and 2027, $0.8 million in 2028, and $3.5 million thereafter. Those commitments are manageable against the current cash position, but the company continues to post large operating losses. The gap between revenue growth and profitability remains the central issue for the business. Software license gains helped the top line, yet higher sales and marketing costs and other expenses pushed the full-year operating loss far beyond the prior year. The company's ability to turn around results will depend on sustaining license momentum, expanding SaaS through AwareID, and controlling costs after the engineering headcount reductions.
Forecast
Reported figures
GAAP, from SEC filings| Metric | Q4 FY2023 | Q3 FY2023 | QoQ | Q4 FY2022 | YoY |
|---|---|---|---|---|---|
| Revenue | $4.4M | $6.4M | -31.5% | $4.1M | +7.7% |
| Gross profit | $4.1M | $6.0M | -30.8% | $3.7M | +11.0% |
| Gross margin | 94.5% | 93.6% | +0.9 pp | 91.6% | +2.9 pp |
| Research & development | $2.2M | $2.3M | -2.2% | $2.3M | -3.8% |
| Sales & marketing | $1.8M | $2.2M | -15.4% | $1.9M | -3.1% |
| General & administrative | $1.9M | $1.6M | +16.8% | $1.5M | +21.0% |
| Total operating expenses | $8.9M | $5.6M | +57.2% | $6.1M | +45.6% |
| Operating income (loss) | -$4.5M | $747.0K | -700.1% | -$2.0M | -121.9% |
| Operating margin | -102.5% | 11.7% | -114.2 pp | -49.7% | -52.8 pp |
| Net income (loss) | -$4.2M | $1.1M | -470.5% | -$1.8M | -141.3% |
| Net margin | -96.9% | 17.9% | -114.8 pp | -43.2% | -53.7 pp |
| Diluted EPS | -$0.20 | $0.05 | -$0.25 | -$0.08 | -$0.12 |
Risks
Individual orders can represent a meaningful percentage of revenues and timing is difficult to predict. The filing states failure to close or deferral or cancellation of an order can cause revenue and net income shortfalls for that quarter, and because operating costs are largely fixed, even a small shortfall could disproportionately affect results. FY2023 revenue rose 14.0% year over year to $18.24 million while operating loss widened 285.2% to $8.54 million.
A significant portion of revenue is derived directly or indirectly from federal, international, state and local governments. The filing cites changes in fiscal policy, decreased government funding, changes in funding priorities, appropriations delays, and delays in invoice payment by government offices as factors that could reduce purchases and materially harm results.
A significant portion of revenue comes through systems integrators, VARs, and OEM partners. The filing warns that these partners are not within direct control and that reduced sales efforts, failure to win awards, misalignment of interests, financial weakness, or termination of a major relationship could materially harm business and operating results.
The biometrics market faces intense competition from diversified providers such as Idemia, Thales, and NEC, and component providers such as FaceTec, iProov, and Innovatrics. Many competitors have substantially greater resources, and low-cost foreign competitors may price aggressively, potentially causing revenue and market share declines.
The fair value of the Omlis Limited note receivable was $0 at December 31, 2023, down from $2.6 million at December 31, 2022. MD&A cites a $2.7 million negative adjustment to a note receivable and states Omlis and MIRACL petitioned to enter the United Kingdom administration process in January 2024, adding uncertainty to recoverability.
The business is subject to extensive federal, state, and foreign privacy and biometric data regulations, including GDPR, CPRA, the Illinois Biometric Privacy Act, the Texas biometric statute, Washington H.B. 1493, and Brazil's LGPD. Compliance costs, fines, or restrictions on biometric data use could materially impact results.
A significant commercial market for biometrics technology may not develop, and adoption has been limited and slow. The filing states commercial markets are still developing and biometrics competes with traditional security methods, so demand uncertainty could limit the company's growth.
The FortressID acquisition included contingent acquisition payments tied to revenue targets. No targets were achieved in 2023 or 2022, the earnout period closed as of December 31, 2023, and a $0.8 million fair value adjustment was recorded in 2023. The filing also notes acquisition integration may not realize anticipated benefits and can disrupt operations.
The filing states key employee departures could cause substantial difficulty in hiring qualified successors and a loss in productivity. MD&A notes engineering headcount decreased from 46 in 2022 to 42 in 2023, and additional actions reduced engineering headcount by approximately 10%, which may heighten execution and retention risk.
Unfavorable economic conditions, including recessions, inflation, financial market turmoil, global crises, the Russia-Ukraine conflict and resulting sanctions, and Middle East conflicts, could reduce demand, increase order cancellations or delays, pressure prices, and raise costs.
The filing states SaaS revenue was de minimis in 2023 and 2022, but AwareID is expected to make SaaS a significant product offering. Market acceptance of cloud-based software is critical, and slower cloud adoption could negatively affect demand for the company's services.
The filing states intellectual property protection is limited, some foreign countries do not provide effective legal protection, and third parties may copy or reverse engineer products. Litigation to enforce IP or defend infringement claims could be costly and divert management attention.
Officers, directors, and holders of at least 5% of outstanding shares beneficially own approximately 48% of common stock, or 60% on a fully diluted basis assuming exercise of vested and unvested options. This concentration may delay or prevent a change in control and significantly influence stockholder actions.
Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q4 FY2023 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Oct 2, 2026.